The "PAX8 Gene Hypothyroidism Congenital Nongoitrous Type 2 Familial Genetic Test" is a specialized diagnostic tool used to identify mutations in the PAX8 gene, which are linked to Congenital Hypothyroidism Nongoitrous Type 2 (CHNG2). This condition is a form of familial thyroid dysgenesis that does not lead to thyroid enlargement (goiter). The PAX8 gene plays a crucial role in thyroid development and function; thus, mutations in this gene can result in thyroid gland abnormalities leading to hypothyroidism from birth.
This genetic test is particularly important for families with a history of the condition, as it can provide essential information for early diagnosis and treatment, which is critical for normal development and preventing severe complications associated with untreated congenital hypothyroidism.
Performed at DNA Labs UAE, the test is available for a cost of 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by professionals specialized in genetic diagnostics, ensuring accurate and reliable test results. Early detection through this test can significantly impact the management and outcome of affected individuals by facilitating timely intervention.
The TSHB Gene Hypothyroidism Congenital Nongoitrous Type 4 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the TSHB gene. These mutations are known to cause Congenital Nongoitrous Hypothyroidism Type 4, a rare form of thyroid dysfunction present from birth. Unlike other forms of congenital hypothyroidism, this type does not lead to goiter formation. The condition results from the thyroid gland's failure to produce sufficient amounts of thyroid hormone, essential for regulating metabolism and growth. Early detection through this genetic test is crucial for timely intervention and management to mitigate potential developmental delays and health issues associated with the disorder. The test is priced at 4400 AED, reflecting the advanced genetic analysis involved in accurately identifying the specific gene mutation.
The THRA Gene Hypothyroidism Congenital Nongoitrous Type 6 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the THRA gene, which are implicated in the development of Congenital Nongoitrous Hypothyroidism Type 6. This condition is a rare thyroid disorder characterized by low levels of thyroid hormone from birth, without the enlargement of the thyroid gland (goiter). The test plays a crucial role in early diagnosis and management of the disorder, enabling healthcare providers to initiate appropriate treatment strategies to manage symptoms and prevent potential complications.
The testing process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for specific genetic mutations in the THRA gene. The accuracy of this genetic test allows for a definitive diagnosis, offering critical insights into the condition that affects thyroid hormone synthesis and action, leading to various developmental and metabolic challenges in affected individuals.
The cost of the THRA Gene Hypothyroidism Congenital Nongoitrous Type 6 Genetic Test at DNA Labs UAE is 4400 AED. Given the specialized nature of this test and its importance in the early detection and treatment of congenital hypothyroidism, the investment is considered valuable for those at risk or showing symptoms of this condition. Early diagnosis through this genetic testing can significantly improve the quality of life and health outcomes for patients, making it a vital tool in the management of congenital hypothyroidism.
The TRHR Gene Hypothyroidism Isolated TRHR Related Genetic Test is a specialized diagnostic examination conducted at DNA Labs UAE, designed to identify mutations in the TRHR gene that are associated with isolated hypothyroidism. Hypothyroidism, a condition where the thyroid gland does not produce enough thyroid hormones, can be due to various causes, including genetic factors. The TRHR gene plays a critical role in the regulation of thyroid hormone production by encoding the thyrotropin-releasing hormone receptor, which is essential for the proper functioning of the thyroid gland.
This test is specifically aimed at individuals who have clinical symptoms of hypothyroidism or a family history of thyroid disorders, where the cause is suspected to be genetic. By analyzing the TRHR gene, healthcare providers can determine if the hypothyroidism is due to mutations in this gene, facilitating a more targeted approach to treatment and management of the condition.
The test is priced at 4400 AED and is performed at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and adherence to high standards of accuracy and reliability. The results from this test can provide crucial information for the effective management of hypothyroidism, enabling personalized treatment plans that address the genetic roots of the condition.
The PREPL Gene Hypotonia-Cystinuria Syndrome Genetic Test is a specialized diagnostic tool designed to identify mutations in the PREPL gene, which are linked to Hypotonia-Cystinuria Syndrome (HCS). HCS is a rare genetic condition characterized by muscle weakness (hypotonia) and an excess of cystine in the urine (cystinuria), among other symptoms. This syndrome can impact various aspects of health, including growth, kidney function, and muscle tone, making early diagnosis crucial for effective management and treatment.
The test involves analyzing the patient's DNA to look for specific mutations in the PREPL gene that are known to cause the syndrome. This genetic testing is pivotal for confirming the diagnosis of HCS, enabling healthcare providers to tailor treatment plans according to the individual's genetic makeup and to offer genetic counseling to the family.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test ensures high accuracy and reliability. The cost of the PREPL Gene Hypotonia-Cystinuria Syndrome Genetic Test is 4400 AED, reflecting the intricate processes and sophisticated technology employed in detecting the genetic mutations associated with the syndrome.
By opting for this test at DNA Labs UAE, patients and their families can gain invaluable insights into the genetic underpinnings of Hypotonia-Cystinuria Syndrome, facilitating informed decisions about care and management of the condition.
The SLC22A12 gene plays a critical role in the regulation of uric acid levels within the body by encoding for a protein that functions as a urate transporter in the kidneys. Mutations in this gene can lead to hypouricemia renal type 1, a condition characterized by abnormally low levels of uric acid in the blood. This condition can result in various health issues, including exercise-induced acute renal failure and urolithiasis.
To diagnose this genetic condition, the SLC22A12 Gene Hypouricemia Renal Type 1 Genetic Test is available. This specialized test is designed to detect mutations in the SLC22A12 gene that are responsible for the condition. By analyzing a patient's DNA, the test can provide crucial information for the diagnosis, management, and treatment of individuals with or at risk of developing hypouricemia renal type 1.
The test is offered at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 4400 AED, which reflects the comprehensive analysis and expert interpretation that accompanies the service. Conducted in a state-of-the-art laboratory by experienced geneticists, the SLC22A12 Gene Hypouricemia Renal Type 1 Genetic Test is a valuable tool for patients and healthcare providers in the management of hypouricemia renal type 1.
The SLC2A9 Gene Hypouricemia Renal Type 2 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the SLC2A9 gene, which are associated with Renal Hypouricemia Type 2. This condition is characterized by abnormally low levels of uric acid in the blood, due to impaired reabsorption and increased excretion of uric acid in the kidneys. Individuals with mutations in the SLC2A9 gene may experience a range of symptoms, from asymptomatic conditions to severe complications like exercise-induced acute kidney injury.
The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of specific genetic mutations in the SLC2A9 gene. The outcome of this test can provide crucial information for the diagnosis, management, and treatment of individuals with or at risk of developing Renal Hypouricemia Type 2.
DNA Labs UAE offers this genetic test at a cost of 4400 AED. The testing process is conducted with high standards of accuracy, confidentiality, and professionalism, ensuring reliable results for patients seeking insights into their genetic predisposition to hypouricemia and its related health implications.
The "MCM4 Gene Immunodeficiency with Natural Killer Cell Deficiency Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the MCM4 gene, which are known to cause immunodeficiency issues, particularly affecting the natural killer (NK) cells. NK cells play a crucial role in the body's immune response by targeting and destroying virally infected cells and tumors. Mutations in the MCM4 gene can lead to a compromised immune system, making individuals more susceptible to infections and certain cancers.
This genetic test is crucial for patients who exhibit symptoms of immunodeficiency or have a family history of related conditions, as it helps in the accurate diagnosis and understanding of their condition. The test involves analyzing the patient's DNA to look for specific mutations in the MCM4 gene that are linked to the deficiency of NK cells.
The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and expertise required to conduct such a specialized genetic test. Conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, patients can expect high standards of accuracy and reliability in their test results, which are essential for the subsequent management and treatment of the condition.
The "CR2 Gene Immunodeficiency Common Variable Type 7 Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE, aimed at detecting mutations in the CR2 gene which are associated with Common Variable Immunodeficiency Type 7 (CVID7). This condition is a primary immunodeficiency disorder characterized by a decreased level of serum immunoglobulins (antibodies), leading to an increased susceptibility to infections. The CR2 gene plays a crucial role in the immune system's response, and mutations in this gene can disrupt immune function, contributing to the symptoms of CVID7.
The test is designed for individuals who exhibit symptoms of immunodeficiency disorders, such as frequent infections, or have a family history of CVID7, providing them with crucial information regarding their genetic predisposition to this condition. By identifying the presence of specific genetic mutations in the CR2 gene, healthcare providers can offer more targeted and effective treatment plans, potentially improving the quality of life for affected individuals.
The cost of the test is set at 4400 AED, reflecting the comprehensive nature of the genetic analysis and the specialized expertise required to interpret the results. Conducted at DNA Labs UAE, a facility known for its advanced genetic testing capabilities and adherence to high standards of accuracy and confidentiality, this test represents a critical step towards personalized medicine in the realm of immunodeficiency disorders.
The MAGT1 Gene Immunodeficiency X-Linked with Magnesium Defect, Epstein-Barr Virus Infection, and Neoplasia Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE. This test is designed to identify mutations in the MAGT1 gene, which can lead to a rare immunodeficiency disorder. This condition is characterized by low magnesium levels, vulnerability to Epstein-Barr virus infections, and an increased risk of developing neoplasia. The MAGT1 gene plays a crucial role in magnesium ion transport within cells, and mutations can disrupt immune system function, leading to the aforementioned complications.
The test is conducted using a sample of the patient's blood or saliva, which is then analyzed for genetic abnormalities in the MAGT1 gene. It is a vital diagnostic tool for individuals showing symptoms related to the disorder or those with a family history of the condition, as early detection can significantly impact management and treatment strategies.
DNA Labs UAE offers this comprehensive genetic test for a cost of 4400 AED. The test is performed in a state-of-the-art laboratory setting by qualified professionals, ensuring high accuracy and reliability of the results. This test is a critical step towards personalized medicine, allowing for tailored treatment plans based on the patient's specific genetic makeup, thereby enhancing the effectiveness of treatment and improving patient outcomes.
